Clinical Estimation of Dental Anxiety

July 20, 2018 updated by: Markus Höglund, Karolinska Institutet
Introduction: Dental anxiety (DA) is treatable and preventable when dental personnel correctly estimate the patient's level of DA. Objective: To evaluate dental personnel's ability to estimate DA.

Study Overview

Status

Completed

Conditions

Detailed Description

Method: All public dental clinics in the region of Östergötland, Sweden, were asked to consecutively recruit adult patients returning for their annual examination. The patient rated DA using the Modified Dental Anxiety Scale (MDAS) and a Visual Analogue Scale of dental anxiety (DA-VAS). The patient also recorded gender, age, level of education and confidence in handling DA. After the examination, the dental personnel estimated the patient's level of DA (eDA) on a VAS. The examiner also recorded gender, age, profession, years of experience, country of education, interest in DA, special education concerning DA and confidence in ability to handle DA.

Study Type

Observational

Enrollment (Actual)

1230

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Östergötland
      • Linköping, Östergötland, Sweden, 58212
        • Centrum för Orofacial Medicin, Torkelbergsgatan 11.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adult patients returning for their annual examination on a public dental clinics in the region of Östergötland, Sweden

Description

Inclusion Criteria:

Adult patients returning for their annual examination on a public dental clinics in the region of Östergötland, Sweden during a two week period.

Exclusion Criteria:

inability to fill in the questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients
All public dental clinics in the region of Östergötland, Sweden, were asked to consecutively recruit adult patients returning for their annual examination
The patient rated their DA using the Modified Dental Anxiety Scale (MDAS)
Dental personnel
All public dental clinics in the region of Östergötland, Sweden were contacted and asked to participate in the study
the dental personnel estimated the patient's level of DA (eDA) on a 100mm VAS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimated Dental anxiety on a 100mm VAS vs MDAS
Time Frame: through study completion, 2 weeks/clinic and a total of aproximatly 6 months
The dental personnel's Clinical estimation of how dentally anxious their patient are (where 0mm represent minimal and 100mm maximal.) compared to the patients one rating of dental anxiety(Measured whit the Modified Dental Anxiety Scale(MDAS) where 5 is minimal and 25 maximal) .
through study completion, 2 weeks/clinic and a total of aproximatly 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The patients Dental Anxiety, measured whit the "Modified Dental Anxiety Scale"(MDAS)
Time Frame: through study completion, 2 weeks/clinic and a total of approximately 6 months
The Patients own ration of how dentally anxious they are. Measured whit the Modified Dental Anxiety Scale(MDAS) where 5 is minimal and 25 maximal
through study completion, 2 weeks/clinic and a total of approximately 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mats Bågesund, Lecturer, Linköpings University, Sweden.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

December 20, 2017

Study Completion (Actual)

February 1, 2018

Study Registration Dates

First Submitted

June 27, 2018

First Submitted That Met QC Criteria

July 20, 2018

First Posted (Actual)

July 23, 2018

Study Record Updates

Last Update Posted (Actual)

July 23, 2018

Last Update Submitted That Met QC Criteria

July 20, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0001 (Cancer Research Institute)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Data will only be presented at group level.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Anxiety

Clinical Trials on MDAS

3
Subscribe